Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Triptolide-induced apoptosis in non-small cell lung cancer via a novel miR204-5p/Caveolin-1/Akt-mediated pathway
Philips, Brian J. , Bürki, Sarah, Ryan, John P. , Noda, Kentaro , D’Cunha, Jonathan, D'Cunha, Jonathan, Kumar, Ajay

Mayo Clinic

Oncotarget | July 14, 2020 | Volume: 11 | Issue: 28 | Pages: 2793-2806

10.18632/oncotarget.27672 | PMID 32733649 Get It

A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas
Monga, Varun , Skubitz, Keith M. , Maliske, Seth , Mott, Sarah L. , Dietz, Hilary , Hirbe, Angela C. , Oppelt, Peter , Okuno, Scott H. , O’Connor, Madeline, Seetharam, ­Mahesh , Attia, Steven , Charlson, John A. , Agulnik, Mark , Milhem, Mohammed , Robinson, Steven, O'Connor, Madeline, Milhem, Mohammed M , Hirbe, Angela C , Skubitz, Keith , Monga, Varun , Tine, Brian A. Van , Oppelt, Peter, Robinson, Steven I.

Mayo Clinic

Cancers | July 14, 2020 | Volume: 12 | Issue: 7 | Pages: 1873

10.3390/cancers12071873 | PMID 32664595 Get It

Although checkpoint inhibitors have been approved in multiple cancers, they are still under investigation in soft tissue sarcoma (STS). We conducted a retrospective review to report the safety, efficacy, and prognostic factors related to checkpoint inhibitors in STS. A sequential cohort of metastatic STS patients from four institutions treated with checkpoint inhibitors was assembled. Logistic and Cox regression models were applied to determine the effect of patient characteristics, prior treatment, and baseline factors on achieving the best overall response of complete response (CR), partial response (PR), or stable disease (SD) as determined by the treating physician. Eighty-eight patients with two median prior therapies received checkpoint inhibitors. Treatments included pembrolizumab in 47, nivolumab in 6, ipilimumab in 1, combination ipilimumab/nivolumab in 27, and other combination immunotherapies in 7 patients. Immunotherapy was discontinued in 54 patients—72.2% for progression, 16.7% for toxicity, and 11.1% for other reasons. Median progression-free survival (PFS) was 4.1 months and median overall survival was 19.1 months. One patient with undifferentiated pleomorphic sarcoma (UPS) achieved a CR, while 20 patients had a PR, including 7 UPS, 9 leiomyosarcoma (LMS), and 1 each with alveolar soft part sarcoma, fibroblastic sarcoma, sclerosing epithelioid fibrosarcoma, and myxofibrosarcoma. Forty-five percent (9 of 20) of LMS patients achieved a PR. Twenty-eight patients had SD. Our results confirm the activity and safety of anti-PD-1 therapy in metastatic STS. A notable response rate was observed in UPS and LMS subtypes. This study expands the knowledge base beyond what is currently available from clinical trials involving checkpoint inhibitors in metastatic STS.
The Influence Of Physical Activity And Body Composition On Gene Expression In Breast Adipose Tissue
Schulte, Hannah K., Neil‐Sztramko, Sarah , Nyamundanda, Gift, Bland, K I, Campbell, Kristin L. , Neil-Sztramko, Sarah , Kannan, Nagarajan , Sadanandam, Anguraj , Little, Jonathan P. , Johnson, James D. , Csizmadi, Ilona , Bland, Kelcey A.

Mayo Clinic

Medicine & Science in Sports & Exercise | July 9, 2020 | Volume: 52 | Issue: 7S | Pages: 984-984

10.1249/01.mss.0000686272.19701.5b Get It

Skeletal Muscle Endurance And Oxygen Uptake Kinetics During Cycling In Patients With High Affinity Hemoglobin
Dominelli, Paolo B. , Shepherd, John R.A. , Wiggins, Chad C. , Senefeld, Jonathon W. , Baker, Sarah E. , Uchida, Kôji , Joyner, Michael J.

Mayo Clinic

Medicine & Science in Sports & Exercise | July 9, 2020 | Volume: 52 | Issue: 7S | Pages: 207-207

10.1249/01.mss.0000675800.49464.37 Get It

The Current Status of Women in Surgery
Stephens, Elizabeth H. , Heisler, Christine A. , Miller, Pringl , Heisler, Christine A. , Temkin, Sarah M.

Mayo Clinic

JAMA Surgery | July 8, 2020 | Volume: 155 | Issue: 9 | Pages: 876

10.1001/jamasurg.2020.0312 | PMID 32639556 Get It

Discontinuation of Oxygen as a Clinical Outcome Measure in Pneumonia with Acute Respiratory Failure
Chalmers, Sarah , Frank, Ryan D. , Odeyemi, Yewande , Lal, Amos , Gajic, Ognjen

Mayo Clinic

A41. CRITICAL CARE: PREDICTING AND MEASURING OUTCOMES | July 8, 2020 | Volume: No volume available | Issue: No issue available | Pages: A1614-A1614

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1614 Get It

False Positive 68 Ga-DOTATATE PET/CT in a Patient with Small Bowel Carcinoid Tumor
Chalmers, Sarah , Thomas, C

Mayo Clinic

C70. THORACIC ONCOLOGY CASE REPORTS: RARE TUMORS AND MIMICS II | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A5839-A5839

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5839 Get It

Class C GPCR Effects on Airway Smooth Muscle Mitochondria
Ahmed, Maaz, Pabelick, C.M., Wicher, Sarah A. , Bartman, Colleen M. , Patel, Brijeshkumar S. , Prakash, Y. S.

Mayo Clinic

C60. ASTHMA: CELLULAR AND ANIMAL MODELS | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A5600-A5600

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5600 Get It

Hyperoxia-Induced Soluble Guanylyl Cyclase (sGC) Dysfunction in Developing Airway Causes Remodeling and Fibrosis
Gandy, A., Ravix, Jovanka, Britt, Rodney D. , Roesler, A.M., Manlove, L., Thompson, Marita, Pabelick, C.M., Wicher, Sarah A. , Thompson, M., Prakash, Y. S.

Mayo Clinic

B108. NEW INSIGHTS INTO AIRWAY REMODELLING AND REPAIR | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A4408-A4408

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4408 Get It